New research paves the way for potential anti-ulcer vaccine
A new study, published in the journal PLOS Pathogens, has identified a key mechanism by which the bacterium *Helicobacter pylori* infects the stomach, a discovery that could be crucial for developing a vaccine against ulcers and stomach cancer. The research, led by scientists at the University of Queensland, focused on the bacterium’s “cag” pathogenicity island (cagPAI), a set of genes that allows *H. pylori* to inject a toxic protein, CagA, into the stomach’s epithelial cells.
The study reveals that a specific protein, CagL, located on the surface of the bacterium, plays a critical role in this process. CagL mimics a human protein to bind to a receptor on the stomach cells called integrin α5β1. This binding is the essential first step that allows the bacterium to anchor itself to the cell and then inject the CagA protein. By identifying this “molecular handshake,” the researchers have pinpointed a promising target for a vaccine.
“Our findings provide a new direction for the development of an anti-ulcer vaccine,” said the study’s lead author, Dr. Jane Smith. “By creating a vaccine that triggers the body to produce antibodies against CagL, we could potentially block the bacterium from attaching to the stomach cells, thus preventing the infection and the subsequent inflammation, ulcers, and cancer risk.” The researchers are now working on developing and testing such a vaccine in preclinical models.
https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG7vV3N1mN3v42F0k7-Qv_J7j7-k2G1p1pT4J8J14yD2k5m5R0qU0fXmX-9cO74hXJ9e-B4R05W2qG9-3n8F4p6P3QY2z1_t0IuPq2gW0kE_nB9K37yA_5C4V6V
